Circular RNAs as biomarkers for lung cancer

Lung cancer is the leading cause of death and morbidity from malignant neoplasms worldwide, and its poor prognosis places a heavy burden on patients. A large percentage of lung cancer cases are associated with smoking. A significant number of non-smokers also develop the disease, suggesting an epige...

Full description

Bibliographic Details
Main Authors: Albert Sufianov, Sema Begliarzade, Aferin Beilerli, Yanchao Liang, Tatiana Ilyasova, Ozal Beylerli
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2023-03-01
Series:Non-coding RNA Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468054022000683
_version_ 1811178280609382400
author Albert Sufianov
Sema Begliarzade
Aferin Beilerli
Yanchao Liang
Tatiana Ilyasova
Ozal Beylerli
author_facet Albert Sufianov
Sema Begliarzade
Aferin Beilerli
Yanchao Liang
Tatiana Ilyasova
Ozal Beylerli
author_sort Albert Sufianov
collection DOAJ
description Lung cancer is the leading cause of death and morbidity from malignant neoplasms worldwide, and its poor prognosis places a heavy burden on patients. A large percentage of lung cancer cases are associated with smoking. A significant number of non-smokers also develop the disease, suggesting an epigenetic and genetic mechanism for the development of lung cancer. The current situation with the diagnosis and treatment of lung cancer remains grim, and effective therapeutic targets and molecular markers are urgently needed. Circular RNAs (circRNAs) are covalently closed non-coding RNAs that have received much attention due to their biological properties such as conservatism, stability, and tissue specificity. Many studies have shown that circRNAs are involved in the regulation of lung cancer through various mechanisms, such as microRNA adsorption, and play an important role in the early diagnosis, treatment, and prognosis of lung cancer. In recent years, it has become increasingly clear that circRNAs are involved in the proliferation, migration, and invasion of lung cancer cells. Differentially expressed circRNAs can be used as non-invasive diagnostic and prognostic markers of lung cancer. This article summarizes the current advances of circRNAs in the diagnosis, treatment and prognosis of lung cancer.
first_indexed 2024-04-11T06:15:44Z
format Article
id doaj.art-da15a130c1064bcb8a7301ad1c9c8992
institution Directory Open Access Journal
issn 2468-0540
language English
last_indexed 2024-04-11T06:15:44Z
publishDate 2023-03-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Non-coding RNA Research
spelling doaj.art-da15a130c1064bcb8a7301ad1c9c89922022-12-22T04:41:03ZengKeAi Communications Co., Ltd.Non-coding RNA Research2468-05402023-03-01818388Circular RNAs as biomarkers for lung cancerAlbert Sufianov0Sema Begliarzade1Aferin Beilerli2Yanchao Liang3Tatiana Ilyasova4Ozal Beylerli5Educational and Scientific Institute of Neurosurgery, Рeoples’ Friendship University of Russia (RUDN University), Moscow, Russia; Department of Neurosurgery, Sechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaRepublican Clinical Perinatal Center, Ufa, Republic of Bashkortostan, 450106, RussiaDepartment of Obstetrics and Gynecology, Tyumen State Medical University, 54 Odesskaya Street, 625023, Tyumen, RussiaDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, ChinaDepartment of Internal Diseases, Bashkir State Medical University, Ufa, Republic of Bashkortostan, 450008, RussiaEducational and Scientific Institute of Neurosurgery, Рeoples’ Friendship University of Russia (RUDN University), Moscow, Russia; Corresponding author. Рeoples’ Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya Street, Moscow, 117198, Russian Federation.Lung cancer is the leading cause of death and morbidity from malignant neoplasms worldwide, and its poor prognosis places a heavy burden on patients. A large percentage of lung cancer cases are associated with smoking. A significant number of non-smokers also develop the disease, suggesting an epigenetic and genetic mechanism for the development of lung cancer. The current situation with the diagnosis and treatment of lung cancer remains grim, and effective therapeutic targets and molecular markers are urgently needed. Circular RNAs (circRNAs) are covalently closed non-coding RNAs that have received much attention due to their biological properties such as conservatism, stability, and tissue specificity. Many studies have shown that circRNAs are involved in the regulation of lung cancer through various mechanisms, such as microRNA adsorption, and play an important role in the early diagnosis, treatment, and prognosis of lung cancer. In recent years, it has become increasingly clear that circRNAs are involved in the proliferation, migration, and invasion of lung cancer cells. Differentially expressed circRNAs can be used as non-invasive diagnostic and prognostic markers of lung cancer. This article summarizes the current advances of circRNAs in the diagnosis, treatment and prognosis of lung cancer.http://www.sciencedirect.com/science/article/pii/S2468054022000683Noncoding RNAsCircular RNAsLung cancerBiology functionBiomarker
spellingShingle Albert Sufianov
Sema Begliarzade
Aferin Beilerli
Yanchao Liang
Tatiana Ilyasova
Ozal Beylerli
Circular RNAs as biomarkers for lung cancer
Non-coding RNA Research
Noncoding RNAs
Circular RNAs
Lung cancer
Biology function
Biomarker
title Circular RNAs as biomarkers for lung cancer
title_full Circular RNAs as biomarkers for lung cancer
title_fullStr Circular RNAs as biomarkers for lung cancer
title_full_unstemmed Circular RNAs as biomarkers for lung cancer
title_short Circular RNAs as biomarkers for lung cancer
title_sort circular rnas as biomarkers for lung cancer
topic Noncoding RNAs
Circular RNAs
Lung cancer
Biology function
Biomarker
url http://www.sciencedirect.com/science/article/pii/S2468054022000683
work_keys_str_mv AT albertsufianov circularrnasasbiomarkersforlungcancer
AT semabegliarzade circularrnasasbiomarkersforlungcancer
AT aferinbeilerli circularrnasasbiomarkersforlungcancer
AT yanchaoliang circularrnasasbiomarkersforlungcancer
AT tatianailyasova circularrnasasbiomarkersforlungcancer
AT ozalbeylerli circularrnasasbiomarkersforlungcancer